Breast Cancer Research

official impact factor 5.79

Viewpoint

Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?

Bryan P Schneider and George W Sledge*

Breast Cancer Research 2009, 11:303 doi:10.1186/bcr2250

No comments have yet been made on this article.

Post a comment